Overview and Scope
A deep brain stimulation (DBS) system is a medical device that uses implanted electrodes to deliver electrical pulses to specific areas of the brain. It is used to regulate abnormal brain activity and improve symptoms associated with a variety of neurological conditions.
Sizing and Forecast
The deep brain stimulation systems market size has grown rapidly in recent years. It will grow from $2.28 billion in 2023 to $2.53 billion in 2024 at a compound annual growth rate (CAGR) of 11.1%. The growth in the historic period can be attributed to rising desire for less invasive operations among the general public, increasing demand for minimally invasive surgery in developed countries, rising demand for minimally invasive surgical procedures, high prevalence of diseases such as parkinson’s disease and epilepsy, increasing prevalence of neurological disorders.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/deep-brain-stimulation-systems-global-market-report
The deep brain stimulation systems market covered in this report is segmented –
1) By Product: Single Channel, Dual Channel
2) By Application: Parkinson’s Disease, Essential Tremor, Obsessive Compulsive Disorder, Epilepsy, Dystonia, Other Applications
3) By End-user: Hospitals, Ambulatory Surgical Centers, Neurological Clinics, Other End Users
North America was the largest region in the deep brain stimulation systems market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the deep brain stimulation systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample_request?id=13834&type=smp
Major Driver Impacting Market Growth
The increasing prevalence of neurological disorders is expected to propel the growth of the deep brain stimulation systems market going forward. Neurological disorders refer to a group of heterogeneous diseases that affect the body’s autonomic, peripheral, and central nervous systems. Deep brain stimulation systems are used in neurosurgical procedures to send electrical stimulation to the desired area, aiming to alter or modulate neural functioning and achieve a reversible, adjustable, and therapeutic effect. For instance, in March 2023, according to the Parkinson’s Foundation, a US-based national organization, nearly 90,000 people were diagnosed with PD every year in the US, a 50% increase from the previously estimated rate of 60,000 diagnoses annually. For instance, in October 2022, according to the Centers for Disease Control and Prevention, a US-based federal agency, up to 5.8 million Americans suffered from Alzheimer’s disease in 2020, and this population is expected to almost triple to 14 million by 2060. Therefore, the increasing prevalence of neurological disorders is driving the growth of the deep brain stimulation systems market.
Key Industry Players
Major companies operating in the deep brain stimulation systems market report are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Quest Diagnostics Inc., St. Jude Medical Inc., Stanford Health Care, Associated Regional and University Pathologists Inc., LivaNova PLC, OPKO Health Inc., Nordic Laboratories, Myriad Genetics Inc., Nevro Corporation, Genomic Health, Mayo Medical Laboratories, Foundation Medicine Inc., SceneRay Co., ACM Global Laboratories, Neuropace Inc., American Esoteric Laboratories, Nexstim Oy, Aleva Neurotherapeutics S.A., NeuroSigma Inc., Beijing PINS Medical Co. Ltd., BioMONTR Labs, Functional Neuromodulation Ltd., Miraca Holdings Inc., Nuvectra Corporation
The deep brain stimulation systems market report table of contents includes:
1. Executive Summary
2. Deep Brain Stimulation Systems Characteristics
3. Deep Brain Stimulation Systems Trends And Strategies
4. Deep Brain Stimulation Systems – Macro Economic Scenario
5. Global Deep Brain Stimulation Systems Size and Growth
…..
32. Global Deep Brain Stimulation Systems Competitive Benchmarking
33. Global Deep Brain Stimulation Systems Competitive Dashboard
34. Key Mergers And Acquisitions In The Deep Brain Stimulation Systems
35. Deep Brain Stimulation Systems Future Outlook and Potential Analysis
36. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
